NO20005216D0 - Sammensetning for behandling av eksterne sekresjonssykdommer unntatt hypolakrimasjon - Google Patents

Sammensetning for behandling av eksterne sekresjonssykdommer unntatt hypolakrimasjon

Info

Publication number
NO20005216D0
NO20005216D0 NO20005216A NO20005216A NO20005216D0 NO 20005216 D0 NO20005216 D0 NO 20005216D0 NO 20005216 A NO20005216 A NO 20005216A NO 20005216 A NO20005216 A NO 20005216A NO 20005216 D0 NO20005216 D0 NO 20005216D0
Authority
NO
Norway
Prior art keywords
hypolacrimation
treatment
composition
secretion disorders
external secretion
Prior art date
Application number
NO20005216A
Other languages
English (en)
Inventor
Ryuji Ueno
Ichie Kato
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Publication of NO20005216D0 publication Critical patent/NO20005216D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20005216A 1999-02-18 2000-10-17 Sammensetning for behandling av eksterne sekresjonssykdommer unntatt hypolakrimasjon NO20005216D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12072599P 1999-02-18 1999-02-18
PCT/JP2000/000810 WO2000048447A2 (en) 1999-02-18 2000-02-15 Composition for treatment of external secretion disorders except hypolacrimation

Publications (1)

Publication Number Publication Date
NO20005216D0 true NO20005216D0 (no) 2000-10-17

Family

ID=22392173

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005216A NO20005216D0 (no) 1999-02-18 2000-10-17 Sammensetning for behandling av eksterne sekresjonssykdommer unntatt hypolakrimasjon

Country Status (11)

Country Link
US (1) US6339088B1 (no)
EP (1) EP1073666A1 (no)
JP (1) JP2003516309A (no)
AR (1) AR029335A1 (no)
AU (1) AU2462400A (no)
BR (1) BR0005010A (no)
CA (1) CA2328877A1 (no)
IL (1) IL139071A0 (no)
MX (1) MXPA00010193A (no)
NO (1) NO20005216D0 (no)
WO (1) WO2000048447A2 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555540B1 (en) * 1999-06-30 2003-04-29 Pfizer Inc Combinations of aldose reductase inhibitors and selective cyclooxygenase-2 inhibitors
JP2002265375A (ja) * 2001-03-13 2002-09-18 Inabata Koryo Kk 唾液分泌促進剤及びこれを含有した食品組成物並びに口腔用組成物
US20040047919A1 (en) * 2002-06-13 2004-03-11 Board Of Regents, The University Of Texas System Methods and compositions involving aldose reductase inhibitors
WO2006013914A1 (ja) * 2004-08-06 2006-02-09 Daiichi Pharmaceutical Co., Ltd. 口腔粘膜投与剤
US20110092566A1 (en) * 2004-11-19 2011-04-21 Srivastava Satish K Treatment of cancer with aldose reductase inhibitors
US8273746B2 (en) * 2007-03-23 2012-09-25 The Board Of Regents Of The University Of Texas System Methods involving aldose reductase inhibitors
US20090270490A1 (en) * 2008-04-24 2009-10-29 The Board Of Regents Of The University Of Texas System Methods involving aldose reductase inhibition
ITUB20152695A1 (it) * 2015-07-31 2017-01-31 Metis Healthcare S R L Composizione per l'aumento delle secrezioni umorali

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8524663D0 (en) * 1985-10-07 1985-11-13 Fujisawa Pharmaceutical Co Quinazoline derivatives
US4931440A (en) 1987-07-29 1990-06-05 Fujisawa Pharmaceutical Company, Ltd. Uricosuric composition
JP2621460B2 (ja) 1988-02-29 1997-06-18 藤沢薬品工業株式会社 利尿または降圧剤
ATE292120T1 (de) * 1998-07-02 2005-04-15 Neurosearch As Kaliumkanal-blockierende mittel
AU2129500A (en) * 1999-01-25 2000-08-07 Fujisawa Pharmaceutical Co., Ltd. Eye drops

Also Published As

Publication number Publication date
AU2462400A (en) 2000-09-04
AR029335A1 (es) 2003-06-25
US6339088B1 (en) 2002-01-15
WO2000048447A3 (en) 2001-01-25
CA2328877A1 (en) 2000-08-24
IL139071A0 (en) 2001-11-25
MXPA00010193A (es) 2002-04-17
BR0005010A (pt) 2002-03-19
EP1073666A1 (en) 2001-02-07
JP2003516309A (ja) 2003-05-13
WO2000048447A2 (en) 2000-08-24

Similar Documents

Publication Publication Date Title
IL147440A0 (en) Composition for treatment of external secretion disorders
PL351134A1 (en) Compositions for treatment of disorders of the oesophagus
NO20014379L (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
NO20040097L (no) Kombinasjoner for behandling av inflammatoriske forstyrrelser
NO20013369D0 (no) Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon
NO20006630D0 (no) Farmasöytisk sammensetning for behandlingen av diabetes
NO20043237L (no) Dihydrobenzodiazepin-2-onderivater for behandling av neurologiske forstyrrelser
NO20026263L (no) Sulfonyl-pyrrolidin-derivater anvendelige for behandling av neurologiske forstyrrelser
NO20022087D0 (no) Fremgangsmåte for behandling av diabetes
NO20005884D0 (no) Kombinasjonsterapi for behandling av bipolare forstyrrelser
NO20041386L (no) Kombinasjoner for bahandling av immunoinflammatoriske forstyrrelser
NO20024775D0 (no) Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
SI1231920T1 (sl) Uporaba epinastina za zdravljenje alergijskega renitisa/konjuktivitisa
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
NO20024777D0 (no) Kinolinyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
NO20024776D0 (no) Hydroksyfenyl-piperazinyl-metyl-benzamidderivater til behandling av smerte
NO20026219L (no) Forbindelser for behandling av svekket fundisk relaksasjon
NO20005216D0 (no) Sammensetning for behandling av eksterne sekresjonssykdommer unntatt hypolakrimasjon
NO20023803L (no) Anvendelse av mirtazapin for behandling av sövnforstyrrelser
NO20020784L (no) Medikament for behandling av brudd
NO991734D0 (no) Pyrazolinoner for behandling av potensforstyrrelser
NO20012612D0 (no) Isonipecotamider for behandling av integren-formidlede lidelser
NO20030717L (no) Forbindelser for behandling av avhengighetsforstyrrelser
DK1200447T3 (da) Oxazinocarbazoler til behandling af CNS-sygdomme
HK1043938A1 (en) Composition for the treatment of psoriasis